File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status

TitleSPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status
Authors
KeywordsDLBCL
SPARC
Tumor microenvironment
Pathology
Lymphoma
Biomarker
Issue Date2021
PublisherElsevier BV. The Journal's web site is located at https://www.journals.elsevier.com/annals-of-oncology
Citation
Annals of Oncology, 2021, v. 32 n. 11, p. 1400-1409 How to Cite?
AbstractBackground: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with respect to outcome. Features of the tumor microenvironment (TME) are associated with prognosis when assessed by gene expression profiling. However, it is uncertain whether assessment of the microenvironment can add prognostic information to the most relevant and clinically well-established molecular subgroups when analyzed by immunohistochemistry (IHC). Patients and methods: We carried out a histopathologic analysis of biomarkers related to TME in a very large cohort (n = 455) of DLBCL treated in prospective trials and correlated with clinicopathologic and molecular data, including chromosomal rearrangements and gene expression profiles for cell-of-origin and TME. Results: The content of PD1+, FoxP3+ and CD8+, as well as vessel density, was not associated with outcome. However, we found a low content of CD68+ macrophages to be associated with inferior progression-free survival (PFS) and overall survival (OS; P = 0.023 and 0.040, respectively) at both univariable and multivariable analyses, adjusted for the factors of the International Prognostic Index (IPI), MYC break and BCL2/MYC and BCL6/MYC double-hit status. The subgroup of PDL1+ macrophages was not associated with survival. Instead, secreted protein acidic and cysteine rich (SPARC)-positive macrophages were identified as the subtype of macrophages most associated with survival. SPARC-positive macrophages and stromal cells directly correlated with favorable PFS and OS (both, P[log rank] <0.001, P[trend] < 0.001). The association of SPARC with prognosis was independent of the factors of the IPI, MYC double-/triple-hit status, Bcl2/c-myc double expression, cell-of-origin subtype and a recently published gene expression signature [lymphoma-associated macrophage interaction signature (LAMIS)]. Conclusions: SPARC expression in the TME detected by a single IHC staining with fair-to-good interobserver reproducibility is a powerful prognostic parameter. Thus SPARC expression is a strong candidate for risk assessment in DLBCL in daily practice.
Persistent Identifierhttp://hdl.handle.net/10722/304458
ISSN
2023 Impact Factor: 56.7
2023 SCImago Journal Rankings: 13.942
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCroci, GA-
dc.contributor.authorAu-Yeung, RKH-
dc.contributor.authorReinke, S-
dc.contributor.authorStaiger, AM-
dc.contributor.authorKoch, K-
dc.contributor.authorOschlies, I-
dc.contributor.authorRichter, J-
dc.contributor.authorPoeschel, V-
dc.contributor.authorHeld, G-
dc.contributor.authorLoeffler, M-
dc.contributor.authorTrümper, L-
dc.contributor.authorRosenwald, A-
dc.contributor.authorOtt, G-
dc.contributor.authorSpang, R-
dc.contributor.authorAltmann, B-
dc.contributor.authorZiepert, M-
dc.contributor.authorKlapper, W-
dc.date.accessioned2021-09-23T09:00:19Z-
dc.date.available2021-09-23T09:00:19Z-
dc.date.issued2021-
dc.identifier.citationAnnals of Oncology, 2021, v. 32 n. 11, p. 1400-1409-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/10722/304458-
dc.description.abstractBackground: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with respect to outcome. Features of the tumor microenvironment (TME) are associated with prognosis when assessed by gene expression profiling. However, it is uncertain whether assessment of the microenvironment can add prognostic information to the most relevant and clinically well-established molecular subgroups when analyzed by immunohistochemistry (IHC). Patients and methods: We carried out a histopathologic analysis of biomarkers related to TME in a very large cohort (n = 455) of DLBCL treated in prospective trials and correlated with clinicopathologic and molecular data, including chromosomal rearrangements and gene expression profiles for cell-of-origin and TME. Results: The content of PD1+, FoxP3+ and CD8+, as well as vessel density, was not associated with outcome. However, we found a low content of CD68+ macrophages to be associated with inferior progression-free survival (PFS) and overall survival (OS; P = 0.023 and 0.040, respectively) at both univariable and multivariable analyses, adjusted for the factors of the International Prognostic Index (IPI), MYC break and BCL2/MYC and BCL6/MYC double-hit status. The subgroup of PDL1+ macrophages was not associated with survival. Instead, secreted protein acidic and cysteine rich (SPARC)-positive macrophages were identified as the subtype of macrophages most associated with survival. SPARC-positive macrophages and stromal cells directly correlated with favorable PFS and OS (both, P[log rank] <0.001, P[trend] < 0.001). The association of SPARC with prognosis was independent of the factors of the IPI, MYC double-/triple-hit status, Bcl2/c-myc double expression, cell-of-origin subtype and a recently published gene expression signature [lymphoma-associated macrophage interaction signature (LAMIS)]. Conclusions: SPARC expression in the TME detected by a single IHC staining with fair-to-good interobserver reproducibility is a powerful prognostic parameter. Thus SPARC expression is a strong candidate for risk assessment in DLBCL in daily practice.-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at https://www.journals.elsevier.com/annals-of-oncology-
dc.relation.ispartofAnnals of Oncology-
dc.subjectDLBCL-
dc.subjectSPARC-
dc.subjectTumor microenvironment-
dc.subjectPathology-
dc.subjectLymphoma-
dc.subjectBiomarker-
dc.titleSPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status-
dc.typeArticle-
dc.identifier.emailAu-Yeung, RKH: rex.auyeung@hku.hk-
dc.identifier.authorityAu-Yeung, RKH=rp01877-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.annonc.2021.08.1991-
dc.identifier.pmid34438040-
dc.identifier.scopuseid_2-s2.0-85115027644-
dc.identifier.hkuros325604-
dc.identifier.volume32-
dc.identifier.issue11-
dc.identifier.spage1400-
dc.identifier.epage1409-
dc.identifier.isiWOS:000710498800012-
dc.publisher.placeNetherlands-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats